mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
BRD-K75293299 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.7 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
AZD1480 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.7 |
mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |